Related Experiment Video
Updated: Sep 25, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression
Asra Mirza1, Qun Wu, Luquan Wang
1Tumor Biology Department, Schering-Plough Research Institute, 2015 Galloping Hill Road, K-15-4 (4600), Kenilworth, NJ 07033, USA.
Abstract:
The temporal gene expression profile during the entire process of apoptosis and cell cycle progression in response to p53 in human ovarian cancer cells was explored with cDNA microarrays representing 33 615 individual human genes. A total of 1501 genes (4.4%) were found to respond to p53 (approximately 80% of these were repressed by p53) using 2.5-fold change as a cutoff. It was anticipated that most of p53 responsive genes resulted from the secondary effect of p53 expression at late stage of apoptosis. To delineate potential p53 direct and indirect target genes during the process of apoptosis and cell cycle progression, microarray data were combined with global p53 DNA-binding site analysis. Here we showed that 361 out of 1501 p53 responsive genes contained p53 consensus DNA-binding sequence(s) in their regulatory region, approximately 80% of which were repressed by p53. This is the first time that a large number of p53-repressed genes have been identified to contain p53 consensus DNA-binding sequence(s) in their regulatory region. Hierarchical cluster analysis of these genes revealed distinct temporal expression patterns of transcriptional activation and repression by p53. More genes were activated at early time points, while more repressed genes were found after the onset of apoptosis. A small-scale quantitative chromatin immunoprecipitation analysis indicated that in vivo p53-DNA interaction was detected in eight out of 10 genes, most of which were repressed by p53 at the early onset of apoptosis, suggesting that a portion of p53 target genes in the human genome could be negatively regulated by p53 via sequence-specific DNA binding. The approaches and genes described here should aid the understanding of global gene regulatory network of p53.
Insights
This study reveals that the tumor suppressor protein p53 represses many genes, particularly during apoptosis and cell cycle progression in ovarian cancer. These findings highlight novel p53-regulated genes and their role in cancer.
Area of Science:
- Molecular Biology
- Cancer Genomics
- Gene Regulation
Background:
- The tumor suppressor protein p53 plays a critical role in cellular responses to stress, including apoptosis and cell cycle arrest.
- Understanding the full spectrum of p53-regulated genes is crucial for deciphering its complex functions in cancer.
Purpose of the Study:
- To comprehensively explore the temporal gene expression changes in response to p53 in human ovarian cancer cells.
- To identify direct and indirect p53 target genes involved in apoptosis and cell cycle progression.
- To characterize the regulatory mechanisms, including transcriptional repression, mediated by p53.
Main Methods:
- Utilized cDNA microarrays to analyze the expression of over 33,000 genes in ovarian cancer cells.
- Integrated microarray data with p53 DNA-binding site analysis to identify direct targets.
- Employed hierarchical clustering to analyze temporal expression patterns.
- Performed quantitative chromatin immunoprecipitation (ChIP) to validate p53-DNA interactions in vivo.
Main Results:
- Identified 1501 genes (4.4%) responsive to p53, with approximately 80% showing repression.
- Found that 361 of these responsive genes contain p53 consensus DNA-binding sequences, predominantly repressed by p53.
- Observed distinct temporal patterns: gene activation at early time points and repression after apoptosis onset.
- Validated in vivo p53-DNA interaction for 8 out of 10 tested genes, many repressed early in apoptosis.
Conclusions:
- This study provides the first large-scale identification of p53-repressed genes containing consensus DNA-binding sites.
- Demonstrates that p53 can negatively regulate a significant portion of its target genes through sequence-specific DNA binding.
- The identified genes and regulatory networks offer insights into p53's role in ovarian cancer progression and therapeutic strategies.
More Related Videos
09:32Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
Published on: September 10, 2017
08:35Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
Published on: January 4, 2012
Related Concept Videos
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Negative Regulator Molecules
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...